{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T13:14:37Z","timestamp":1770988477959,"version":"3.50.1"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,4]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Milrinone, an inotropic agent used ubiquitously in children after cardiac surgery, accumulates in acute kidney injury (AKI). We assessed if urinary AKI biomarkers are predictive of an increase in milrinone concentrations in infants after cardiac surgery.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Multicenter prospective pilot study of infants undergoing cardiac surgery. Urinary AKI biomarkers were measured in the urine at specific time intervals after cardiopulmonary bypass initiation. AKI was defined using the Kidney Disease: Improving Global Outcomes serum creatinine criteria. Serum milrinone concentrations were measured at specific intervals after drug initiation, dose changes, and termination. Excessive milrinone activity was defined as a 20% increase in serum concentration between 6 and 36 hours after initiation. The temporal relationship between urinary AKI biomarker concentrations and a 20% increase in milrinone concentration was assessed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>AKI occurred in 31 (33%) of infants. Milrinone clearance was lower in patients with AKI (4.2 versus 5.6 L\/h\/70 kg; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.02). Excessive milrinone activity was associated with development of serum creatinine\u2013defined AKI [odds ratio (OR) 3.0; 95% confidence interval (CI), 1.21\u20137.39; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.02]. Both tissue inhibitor metalloproteinase type 2 and insulin-like growth factor\u2013binding protein type 7 (TIMP-2*IGFBP-7) \u22650.78 at 12 hours (OR 2.72; 95% CI, 1.01\u20137.38; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.04) and kidney injury molecule 1 (KIM-1) \u2265529.57 at 24 hours (OR 2.76; 95% CI, 1.06\u20137.17; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.04) predicted excessive milrinone activity before a diagnosis of AKI.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>In this pilot study, urine TIMP-2*IGFBP-7 and KIM-1 were predictive of AKI and excessive milrinone activity. Future studies that include a pharmacodynamics assessment of patient hemodynamics, excessive milrinone activity, and AKI biomarker concentrations may be warranted to integrate this concept into clinical practice.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ftd.0000000000000496","type":"journal-article","created":{"date-parts":[[2018,3,11]],"date-time":"2018-03-11T23:27:19Z","timestamp":1520810839000},"page":"186-194","source":"Crossref","is-referenced-by-count":23,"title":["Acute Kidney Injury Biomarkers Predict an Increase in Serum Milrinone Concentration Earlier Than Serum Creatinine\u2013Defined Acute Kidney Injury in Infants After Cardiac Surgery"],"prefix":"10.1097","volume":"40","author":[{"given":"Katja M.","family":"Gist","sequence":"first","affiliation":[{"name":"Division of Pediatric Cardiology, Department of Pediatrics, The Heart Institute, The University of Colorado, Children's Hospital Colorado, Aurora, Colorado;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David S.","family":"Cooper","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Wrona","sequence":"additional","affiliation":[{"name":"Division of Pediatric Cardiology, Department of Pediatrics, The Heart Institute, The University of Colorado, Children's Hospital Colorado, Aurora, Colorado;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Faubel","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Renal Disease and Hypertension, University of Colorado Anschutz Medical Campus, Aurora, Colorado;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Altmann","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Renal Disease and Hypertension, University of Colorado Anschutz Medical Campus, Aurora, Colorado;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiqian","family":"Gao","sequence":"additional","affiliation":[{"name":"Heart Institute Research Core, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley S.","family":"Marino","sequence":"additional","affiliation":[{"name":"The Heart Center, Divisions of Cardiology and Critical Care Medicine, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Alten","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Pediatric Cardiac Critical Care Medicine, University of Alabama, Children's of Alabama, Birmingham, Alabama;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristal M.","family":"Hock","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Pediatric Cardiac Critical Care Medicine, University of Alabama, Children's of Alabama, Birmingham, Alabama;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Mizuno","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander A.","family":"Vinks","sequence":"additional","affiliation":[{"name":"Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie S.","family":"Joy","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael F.","family":"Wempe","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael R.","family":"Bennett","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Center for Acute Care Nephrology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart L.","family":"Goldstein","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio;"},{"name":"Heart Institute Research Core, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio;"},{"name":"Department of Pediatrics, Center for Acute Care Nephrology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230928","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1161\/01.CIR.0000051365.81920.28","article-title":"Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease","volume":"107","author":"Hoffman","year":"2003","journal-title":"Circulation."},{"key":"R2-20230928","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1067\/mhj.2001.111404","article-title":"Pharmacodynamic effects of milrinone with and without a bolus loading infusion","volume":"141","author":"Baruch","year":"2001","journal-title":"Am Heart J."},{"key":"R3-20230928","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/s00246-005-0881-z","article-title":"Milrinone and low cardiac output following cardiac surgery in infants: is there a direct myocardial effect?","volume":"26","author":"Duggal","year":"2005","journal-title":"Pediatr Cardiol."},{"key":"R4-20230928","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s10354-011-0869-7","article-title":"The role of milrinone in children with cardiovascular compromise: review of the literature","volume":"161","author":"Meyer","year":"2011","journal-title":"Wien Med Wochenschr."},{"key":"R5-20230928","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1097\/FTD.0000000000000214","article-title":"Retrospective evaluation of milrinone pharmacokinetics in children with kidney injury","volume":"37","author":"Gist","year":"2015","journal-title":"Ther Drug Monit."},{"key":"R6-20230928","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1002\/jps.2600731029","article-title":"Oral and intravenous pharmacokinetics of milrinone in human volunteers","volume":"73","author":"Stroshane","year":"1984","journal-title":"J Pharm Sci."},{"key":"R7-20230928","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/BF00635891","article-title":"Pharmacokinetics and effects on blood pressure of a single oral dose of milrinone in healthy subjects and in patients with renal impairment","volume":"29","author":"Larsson","year":"1986","journal-title":"Eur J Clin Pharm."},{"key":"R8-20230928","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1054\/jcaf.2001.24136","article-title":"A randomized multicenter study comparing the efficacy and safety of intravenous milrinone and intravenous nitroglycerin in patients with advanced heart failure","volume":"7","author":"Loh","year":"2001","journal-title":"J Card Fail."},{"key":"R9-20230928","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1213\/01.ane.0000198626.67391.34","article-title":"Population pharmacokinetics of milrinone in neonates with hypoplastic left heart syndrome undergoing stage I reconstruction","volume":"102","author":"Zuppa","year":"2006","journal-title":"Anesth Analg."},{"key":"R10-20230928","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1460-9592.2011.03536.x","article-title":"Tips and traps analyzing pediatric PK data","volume":"21","author":"Anderson","year":"2011","journal-title":"Paediatr Anaesth."},{"key":"R11-20230928","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s001340051322","article-title":"Pharmacokinetics of milrinone in patients with congestive heart failure during continuous venovenous hemofiltration","volume":"26","author":"Taniguchi","year":"2000","journal-title":"Intensive Care Med."},{"key":"R12-20230928","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1023\/B:JOPA.0000029488.45177.48","article-title":"A population pharmacokinetic analysis of milrinone in pediatric patients after cardiac surgery","volume":"31","author":"Bailey","year":"2004","journal-title":"J Pharmacokinet Pharmacodyn."},{"key":"R13-20230928","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1177\/1074248413489773","article-title":"Elevation of plasma milrinone concentrations in stage D heart failure associated with renal dysfunction","volume":"18","author":"Cox","year":"2013","journal-title":"J Cardiovasc Pharmacol Ther."},{"key":"R14-20230928","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jtcvs.2011.06.021","article-title":"Congenital heart surgery in infants: effects of acute kidney injury on outcomes","volume":"143","author":"Blinder","year":"2012","journal-title":"J Thorac Cardiovasc Surg."},{"key":"R15-20230928","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1097\/CCM.0b013e31821201d3","article-title":"Incidence, risk factors, and outcomes of acute kidney injury after pediatric cardiac surgery: a prospective multicenter study","volume":"39","author":"Li","year":"2011","journal-title":"Crit Care Med."},{"key":"R16-20230928","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1681\/ASN.2008060617","article-title":"Reduced production of creatinine limits its use as marker of kidney injury in sepsis","volume":"20","author":"Doi","year":"2009","journal-title":"J Am Soc Nephrol."},{"key":"R17-20230928","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1093\/clinchem\/26.8.1119","article-title":"Creatinine: a review","volume":"26","author":"Narayanan","year":"1980","journal-title":"Clin Chem."},{"key":"R18-20230928","doi-asserted-by":"crossref","first-page":"51","DOI":"10.7812\/tpp\/11-121","article-title":"False estimates of elevated creatinine","volume":"16","author":"Samra","year":"2012","journal-title":"Perm J."},{"key":"R19-20230928","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1016\/j.jacc.2011.08.017","article-title":"Temporal relationship and predictive value of urinary acute kidney injury biomarkers after pediatric cardiopulmonary bypass","volume":"58","author":"Krawczeski","year":"2011","journal-title":"J Am Coll Cardiol."},{"key":"R20-20230928","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1007\/s00467-017-3655-y","article-title":"Kinetics of the cell cycle arrest biomarkers (TIMP-2*IGFBP-7) for prediction of acute kidney injury in infants after cardiac surgery","volume":"32","author":"Gist","year":"2017","journal-title":"Pediatr Nephrol."},{"key":"R21-20230928","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/jac\/dkw351","article-title":"Urinary kidney injury biomarkers and tobramycin clearance among children and young adults with cystic fibrosis: a population pharmacokinetic analysis","volume":"72","author":"Downes","year":"2017","journal-title":"J Antimicrob Chemother."},{"key":"R22-20230928","doi-asserted-by":"crossref","first-page":"720","DOI":"10.3109\/15563650.2011.615319","article-title":"Earlier recognition of nephrotoxicity using novel biomarkers of acute kidney injury","volume":"49","author":"Waring","year":"2011","journal-title":"Clin Toxicol (Phila)."},{"key":"R23-20230928","first-page":"1","article-title":"KDIGO clinical practice guideline for acute kidney injury","volume":"2","year":"2012","journal-title":"Kidney Int Suppl."},{"key":"R24-20230928","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1611391","article-title":"Epidemiology of acute kidney injury in critically ill children and young adults","volume":"376","author":"Kaddourah","year":"2017","journal-title":"N Engl J Med."},{"key":"R25-20230928","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.jtcvs.2009.03.071","article-title":"An empirically based tool for analyzing mortality associated with congenital heart surgery","volume":"138","author":"O'Brien","year":"2009","journal-title":"J Thorac Cardiovasc Surg."},{"key":"R26-20230928","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2215\/CJN.04010907","article-title":"Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study","volume":"3","author":"Bennett","year":"2008","journal-title":"Clin J Am Soc Nephrol."},{"key":"R27-20230928","doi-asserted-by":"crossref","first-page":"128","DOI":"10.7150\/ijbs.5.128","article-title":"Assay validation for KIM-1: human urinary renal dysfunction biomarker","volume":"5","author":"Chaturvedi","year":"2009","journal-title":"Int J Biol Sci."},{"key":"R28-20230928","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1161\/HYPERTENSIONAHA.116.08258","article-title":"Association of kidney function and early kidney injury with incident hypertension in HIV-infected women","volume":"69","author":"Ascher","year":"2017","journal-title":"Hypertension."},{"key":"R29-20230928","doi-asserted-by":"crossref","first-page":"e0164832","DOI":"10.1371\/journal.pone.0164832","article-title":"Storage time and urine biomarker levels in the ASSESS-AKI study","volume":"11","author":"Liu","year":"2016","journal-title":"PLoS One."},{"key":"R30-20230928","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1681\/ASN.2010111163","article-title":"Postoperative biomarkers predict acute kidney injury and poor outcomes after pediatric cardiac surgery","volume":"22","author":"Parikh","year":"2011","journal-title":"J Am Soc Nephrol."},{"key":"R31-20230928","first-page":"783","article-title":"A pharmacokinetic and pharmacodynamic evaluation of milrinone in adults undergoing cardiac surgery","volume":"81","author":"Butterworth","year":"1995","journal-title":"Anesth Analg."},{"key":"R32-20230928","doi-asserted-by":"crossref","first-page":"F204","DOI":"10.1136\/adc.2005.092817","article-title":"Population pharmacokinetics and dosing regimen design of milrinone in preterm infants","volume":"92","author":"Paradisis","year":"2007","journal-title":"Arch Dis Child Fetal Neonatal Ed."},{"key":"R33-20230928","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.1097\/PCC.0b013e3182772f61","article-title":"Acute kidney injury based on corrected serum creatinine is associated with increased morbidity in children following the arterial switch operation","volume":"14","author":"Basu","year":"2013","journal-title":"Pediatr Crit Care Med."},{"key":"R34-20230928","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1213\/00000539-199802000-00011","article-title":"Pharmacokinetics and side effects of milrinone in infants and children after open heart surgery","volume":"86","author":"Ramamoorthy","year":"1998","journal-title":"Anesth Analg."}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00007691-201804000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T01:06:44Z","timestamp":1695863204000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007691-201804000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000000496","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]}}}